- - 43. Other Administrative Expenses 44. Depreciation and Amortization About this Report Chairman's Foreword Corporate Management Report Appendices Governance Consolidated Financial Company Financial Statements Statements only aftervesting (aftera period of three orfive years). 50%ofthe direct and the deferred portion of the variable remuneration is allocated in the form of an instrument (instrument component) i.e. the Deferred Remuneration Note (DRN). The value of a DRN is linked directly to the price of a Rabobank Certificate (RC) as listed on the NYSE Euronext. The instrument component is converted into DRNs at the time of allocation on completion of the performance year. The number of DRNs is determined on the basis of the closing rates for Rabobank Certificates, as traded on the NYSE Euronext during the first five trading days of February of each year. This therefore represents both the instrument component of the direct and the deferred portion of the variable remuneration. The final number of DRNs relating to the deferred portion is established on vesting (after a period of three or five years). The payment of the instrument component is subject to a one year retention period. After the end of the retention period, the employee receives, for each DRN (or a portion thereof) an amount in cash that corresponds with the value of the DRN at that moment. Payment ofthe variable remuneration is measured in accordance with IAS 19 Employee benefits. The immediate portion ofthe variable remuneration is recognized in the performance year, whereas the deferred portion is recognised in the years before vesting. On 31 December 2018 Year of payment Amounts in millions of euros 2019 2020 2021 2022 2023 2024 2025 Total Variable remuneration, excluding DRNs 181.0 13.4 3.5 1.7 0.1 0.1 199.8 DRNs 10.2 15.8 10.6 3.2 1.7 0.1 0.1 41.8 Total 191.2 29.2 14.2 4.9 1.8 0.2 0.1 241.6 On 31 December 2017 Year of payment Amounts in millions of euros 2018 2019 2020 2021 2022 Total Variable remuneration, excluding DRNs 175.6 10.1 12.2 1.9 199.9 DRNs 11.6 12 9.7 10.6 1.8 45.8 Total 187.2 22.2 21.9 12.5 1.8 245.7 Amounts in millions of euros 2018 2017 Amounts in millions of euros 2018 2017 Additions and releases of provisions 262 721 Depreciation of property and equipment 244 238 IT expenses and software costs 809 751 Amortization of intangible assets 144 168 Consultants fees 420 395 Depreciation and amortization 388 406 Training and travelling expenses 206 190 Publicity expenses 151 152 Result on derecognition and impairments on (in)tangible assets 66 119 Other expenses 866 848 Other administrative expenses 2,780 3,176 The same system also applies, in broad terms, to non-identified staff, although no deferral policy applies to the first one hundred thousand euros and both the immediate and the deferred portion are paid fully in cash, which means that no DRNs are awarded. On December 31, 2018, the costs of equity instrument-based payments were EUR 14 million (2017: EUR 14 million) and a liability of EUR 34 million was recognized (2017: EUR 35 million) of which EUR 16 million (2017: EUR 12 million) was vested. The costs of variable remuneration paid in cash were EUR 180 million (2017: EUR 177 million). The number of DRNs outstanding is presented in the following table. in thousands 2018 2017 Opening balance 1,412 1,370 Awarded during the year 455 415 Paid during the year (348) (353) Changes from previous year (35) (20) Closing balance 1,484 1,412 The value of a DRN is linked directly to the price of a Rabobank Certificate. The estimated payments to be made for the variable remuneration are shown in the following table. Annual Report 2018 - Consolidated Financial Statements 205

Rabobank Bronnenarchief

Annual Reports Rabobank | 2018 | | pagina 207